Physician profile
Christopher Odom
NPI 1336520469
$29,827.25
in general payments reported to CMS, 2019-2025
18 companies · $3,857 in 2025
The $3,857 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19K · 2022: $1,838 · 2023: $3,643 · 2024: $1,665 · 2025: $3,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,003 · Food and Beverage: $4,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,002.57 |
| Food and Beverage | $4,162.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17,629.99 | 2021-2024 | Journey, Or3o Dual Mobility, Ri Hip Navigation |
| Stryker Corporation | $5,011.00 | 2021-2025 | Mako, Insignia, Accolade |
| Corentec America INC | $3,278.02 | 2025 | Corentec |
| Pylant Medical | $2,400.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $441.60 | 2022-2023 | Rosa, Persona |
| Depuy Synthes Sales INC. | $194.70 | 2021-2025 | Va-Lcp, Monovisc, Orthovisc |
| Microport Orthopedics INC | $129.94 | 2021 | |
| Curonix LLC | $126.00 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Uoc USA INC | $116.25 | 2025 | U2 Pf+ |
| Medacta USA, INC. | $106.64 | 2023 | Gmk Revision |
| Ferring Pharmaceuticals INC. | $95.26 | 2021-2025 | Euflexxa |
| Bioventus LLC | $85.78 | 2025 | Durolane |
| Itamar Medical INC | $52.24 | 2025 | Watchpatone |
| Sanofi-Aventis U.S. LLC | $51.20 | 2023 | |
| Vericel Corporation | $41.64 | 2023-2025 | Maci |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $33.58 | 2022 | |
| Amgen INC. | $18.36 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $15.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Odom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.